Skip to content

Medical-device intelligence

Diagnostica Stago, Inc.: FDA clearances and recalls

Research Diagnostica Stago, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

17 clearance records and 42 recall records in the covered releases, across 1 source company names and 19 product codes. Dated history runs from Feb 12, 2001 to Sep 24, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202501
January 202600
February 202602
March 202600
April 202610
May 202600
June 202600
July 202601
August 202600
September 202610
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

59 matching records
Device / recordCompany in FDA recordSourceSource date
STA - Neoplastine Cl Plus (ref. 00606) Product Usage: Manual or automated determination of the prothrombin time (PT).Z-1069-2018 · GJSDiagnostica Stago, Inc.RecallMar 15, 2018FDA record creation date
Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Ana…Z-2650-2014 · KFFDiagnostica Stago, Inc.RecallSep 16, 2014FDA classification date
STA- COAG CONTROL (N+ABN) PLUSK120014 · GGNDiagnostica Stago, Inc.510(k)Mar 14, 2013FDA decision date
Vial Label: 1) LIATEST VWF:Ag Buffer - 5 ml Diagnostica Stago 2) LIATEST VWF:Ag Latex + 4 ml R3 Diagnostica Stago 3) LIATEST VWF:Ag Latex Dilu…Z-0951-2013 · GJTDiagnostica Stago, Inc.RecallMar 14, 2013FDA classification date
STA Satellite Automated Multi-Parameter Analyzer This system is a fully automatic clinical instrument indicated and intended for the performan…Z-0252-2013 · JPADiagnostica Stago, Inc.RecallNov 6, 2012FDA classification date
STA - System Control N + P Product Usage: The STA -System Control N+P kit provides a normal plasma and an abnormal plasma intended for use as tw…Z-1044-2012 · GGNDiagnostica Stago, Inc.RecallFeb 16, 2012FDA classification date
STA(R) - LIQUID ANTI-XA, MULTI HEP CALIBRATOR, QUALITY HNF / UFH, QUALITY HBPM / LMWHK111822 · KFFDiagnostica Stago, Inc.510(k)Oct 26, 2011FDA decision date
STA-HYBRID HEP CALIBRATORK092937 · JITDiagnostica Stago, Inc.510(k)Aug 2, 2010FDA decision date
STA LIATEST FREE PSK092170 · GGPDiagnostica Stago, Inc.510(k)Dec 22, 2009FDA decision date
STA COMPACT AUTOMATED MULTI-PARAMETRIC ANALYZERK093167 · JPADiagnostica Stago, Inc.510(k)Dec 22, 2009FDA decision date
STA - FREE PS CALIBRATORK092113 · JIXDiagnostica Stago, Inc.510(k)Nov 13, 2009FDA decision date
STA Neoplastine CI 10; Product Catalogue Number: 0666; Manufactured by Diagnostica Stago, Asnieres, France.Z-0501-2009 · GJSDiagnostica Stago, Inc.RecallDec 18, 2008FDA classification date
STA Neoplastine CI Plus 10; Product Catalogue Number: 0667 Manufactured by Diagnostica Stago, Asnieres, France.Z-0502-2009 · GJSDiagnostica Stago, Inc.RecallDec 18, 2008FDA classification date
STA SATELLITE AUTOMATED MULTI-PARAMETER ANALYZERK082248 · JPADiagnostica Stago, Inc.510(k)Dec 12, 2008FDA decision date
STA-R EVOLUTION AUTOMATED MULTI-PARAMETRIC ANALYZERK082675 · JPADiagnostica Stago, Inc.510(k)Oct 10, 2008FDA decision date
STA Compact and STA Compact CT, Haemostasis Analyzer, in vitro diagnostic.Z-0039-2008 · GKPDiagnostica Stago, Inc.RecallOct 11, 2007FDA classification date
STA Liatest Free Protein S For in vitro diagnostic use. 2-8 degrees C Distributed in the USA by: Diagnostica Stago, Inc. 5 Century Drive Parsippa…Z-1072-2007 · GGPDiagnostica Stago, Inc.RecallAug 9, 2007FDA classification date
STA Liatest VWF:Ag, Product Catalog Number : 0518. This is a Immuno-Turbidimetric Assay of von Willebrand Factor.Z-0853-2007 · GGPDiagnostica Stago, Inc.RecallJul 3, 2007FDA classification date
STA Neoplastine CI Plus (10), (cat. 0667). 12 x 10 ml. in vitro diagnostic for the determination of prothrombin time (PT).Z-0979-2007 · GJSDiagnostica Stago, Inc.RecallJul 3, 2007FDA classification date
STA Compact and STA Compact CT For in vitro Diagnostic Use Only In vitro diagnostic analyzer Diagnostica Stago FranceZ-0812-2007 · GKPDiagnostica Stago, Inc.RecallMay 16, 2007FDA classification date
STA - STACLOT DRVV SCREEN; STA - STACLOT DRVV CONFIRMK061805 · GIRDiagnostica Stago, Inc.510(k)Dec 6, 2006FDA decision date
Staclot LA 20 tests, Catalog #0594, LA Assay, Hexagonal Phase Phospholipid Neutralization Assay.Z-1441-06 · GFODiagnostica Stago, Inc.RecallAug 26, 2006FDA classification date
STA - CONTROL LA 1+2K061803 · GGCDiagnostica Stago, Inc.510(k)Jul 28, 2006FDA decision date
STA-CEPHASCREEN KITK053111 · GFODiagnostica Stago, Inc.510(k)May 4, 2006FDA decision date
STA Liatest Free Protein S, cat. 00516. These kits are intended for use with analyzers of the STA brand name for the quantitative determination …Z-0408-06 · GGPDiagnostica Stago, Inc.RecallJan 20, 2006FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗